12:00 AM
Nov 11, 2013
 |  BC Week In Review  |  Company News  |  Deals

OncoMed, Bayer deal

OncoMed said it received a $15 million milestone payment from Bayer under a 2010 deal to discover and develop antibodies, proteins and small molecules targeting...

Read the full 104 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >